DIO Diomed Holdings,

Diomed Holdings, Inc. (AMEX: DIO), a leading developer and marketer of minimally invasive medical technologies, including its patented EndoVenous Laser Treatment (EVLT�) for varicose veins, today announced that it will host a conference call to review the company�s third quarter ended September 30, 2006 financial results. The call will be conducted on Thursday, October 26, 2006, at 10:00 a.m. (ET) and will be hosted by James A. Wylie, Jr., President and Chief Executive Officer, and David B. Swank, Chief Financial Officer. The company's financial results are scheduled to be released earlier that day. Interested parties may access the conference call by dialing 866-831-6162 (domestic) or 617-213-8852 (international), participant pass code 146644724. The call will also be available via web cast at www.diomedinc.com. If you are unable to participate, an audio digital replay of the call will be available from Thursday, October 26, 2006, 12:00 p.m. ET, until Thursday, November 2, 2006, 12:00 p.m. ET. The digital replay can be accessed by dialing 1-888-286-8010, (domestic) or 1-617-801-6888 - (international), using pass code 92289158. A web archive will also be available during this time period at www.diomedinc.com. About Diomed Diomed develops and commercializes minimal and micro-invasive medical procedures that use its proprietary laser technologies and disposable products. Diomed�s EVLT� laser vein ablation procedure is used in varicose vein treatments. Diomed also provides photodynamic therapy (PDT) for use in cancer treatments, and dental and general surgical applications. The EVLT� procedure and the Company�s related products were cleared by the United States FDA in January of 2002. Along with lasers and single-use procedure kits for its EVLT� laser vein treatment, the Company provides its customers with state of the art physician training and practice development support. Additional information is available on the Company�s website: www.evlt.com. EVLT� is a registered trademark of Diomed Inc., Andover, MA. Diomed Holdings, Inc. (AMEX: DIO), a leading developer and marketer of minimally invasive medical technologies, including its patented EndoVenous Laser Treatment (EVLT(R)) for varicose veins, today announced that it will host a conference call to review the company's third quarter ended September 30, 2006 financial results. The call will be conducted on Thursday, October 26, 2006, at 10:00 a.m. (ET) and will be hosted by James A. Wylie, Jr., President and Chief Executive Officer, and David B. Swank, Chief Financial Officer. The company's financial results are scheduled to be released earlier that day. Interested parties may access the conference call by dialing 866-831-6162 (domestic) or 617-213-8852 (international), participant pass code 146644724. The call will also be available via web cast at www.diomedinc.com. If you are unable to participate, an audio digital replay of the call will be available from Thursday, October 26, 2006, 12:00 p.m. ET, until Thursday, November 2, 2006, 12:00 p.m. ET. The digital replay can be accessed by dialing 1-888-286-8010, (domestic) or 1-617-801-6888 - (international), using pass code 92289158. A web archive will also be available during this time period at www.diomedinc.com. About Diomed Diomed develops and commercializes minimal and micro-invasive medical procedures that use its proprietary laser technologies and disposable products. Diomed's EVLT(R) laser vein ablation procedure is used in varicose vein treatments. Diomed also provides photodynamic therapy (PDT) for use in cancer treatments, and dental and general surgical applications. The EVLT(R) procedure and the Company's related products were cleared by the United States FDA in January of 2002. Along with lasers and single-use procedure kits for its EVLT(R) laser vein treatment, the Company provides its customers with state of the art physician training and practice development support. Additional information is available on the Company's website: www.evlt.com. EVLT(R) is a registered trademark of Diomed Inc., Andover, MA.